{
    "title": "BeiGene to go solo with cancer drug after Novartis deal termination",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12535341/BeiGene-regains-rights-cancer-drug-Novartis-deal-termination.html",
    "date": "2023-09-19",
    "keywords": [
        "drug",
        "cancer",
        "deal",
        "roy",
        "tevimbra",
        "treatment",
        "pd1",
        "inhibitor",
        "review",
        "drugmaker",
        "hong",
        "tuesday",
        "discontinuation",
        "tislelizumab",
        "royalty",
        "class",
        "monoclonal",
        "antibody",
        "bodys",
        "immune",
        "system",
        "detect",
        "attack",
        "keytruda",
        "merck",
        "opdivo",
        "lung",
        "termination",
        "strategy",
        "category",
        "agreement",
        "landscape",
        "july",
        "plug",
        "use",
        "commission",
        "decision",
        "partnership",
        "beigene",
        "stone",
        "franchise",
        "driver",
        "analyst",
        "yaron",
        "food",
        "administration",
        "secondline",
        "regulator",
        "china",
        "company",
        "hopeful",
        "conclusion",
        "end",
        "year",
        "mark",
        "lanasa",
        "officer",
        "unit",
        "reporting",
        "bengaluru",
        "editing",
        "shilpi",
        "majumdar",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}